NCT03926286View on ClinicalTrials.gov

Fecal Microbial Transplant (FMT) for Sjogrens Syndrome

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
Sjogren's Syndrome
Interventions
DRUG

FMP-30

FMP-30 containing frozen human fecal microbiota administered as (3) units of FMP30 enema on Day 0 and Week1

Trial Locations (1)

33133

University of Miami, Miami

Sponsors
All Listed Sponsors
collaborator

Sjogrens Syndrome Foundation

UNKNOWN

collaborator

Microbiome Health Research Institute

OTHER

lead

University of Miami

OTHER

NCT03926286 - Fecal Microbial Transplant (FMT) for Sjogrens Syndrome | Biotech Hunter | Biotech Hunter